ARNHEM, the Netherlands - Akzo Nobel announced that it will apply for deregistration and termination of its reporting obligations under the U.S. Securities Exchange Act of 1934 and delisting of its American Depositary Receipts (ADRs) from the NASDAQ stock exchange.

The company will shortly provide written notice to the NASDAQ of its intent to delist and will file the necessary forms with the Securities and Exchange Commission (SEC) and NASDAQ.

Akzo Nobel intends to maintain its ADR facility with Deutsche Bank as a Level One program, meaning that its ADRs will be traded on the over-the-counter market known as International OTCQX. Its common shares will continue to be traded on Euronext Amsterdam.